Olema Pharmaceuticals, Inc. (OLMA)
13.68
-0.38
(-2.70%)
USD |
NASDAQ |
May 22, 16:00
13.56
-0.12
(-0.88%)
After-Hours: 20:00
Olema Pharmaceuticals EPS Diluted (Quarterly) : -0.5164 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -0.1029 |
| Protagonist Therapeutics, Inc. | 0.0537 |
| Cogent Biosciences, Inc. | -0.60 |
| Disc Medicine, Inc. | -1.650 |
| Nuvalent, Inc. | -1.389 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.09M |
| Total Expenses (Quarterly) | 53.09M |
| Enterprise Value | 693.52M |
| Earnings Yield | -14.80% |
| Normalized Earnings Yield | -14.81 |